Evidence map›Paper›PMID 23754744›Full record

ArticleMolecular and cellular biology2013

ATM mediates pRB function to control DNMT1 protein stability and DNA methylation.

Awad Shamma, Misa Suzuki, Naoyuki Hayashi, Masahiko Kobayashi, Nobunari Sasaki, Takumi Nishiuchi, Yuichiro Doki, Takahiro Okamoto, Susumu Kohno, Hayato Muranaka and 3 more

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 0 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Cancers · 2023
    Article
  5. Article
  6. Article
  7. TargetingCancers · 2021
    Review
  8. [DNMT1 protein promotes retinoblastoma proliferation by silencing MEG3 gene].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2020
    Article
  9. Article
  10. MEG3: an Oncogenic Long Non-coding RNA in Different Cancers.Pathology oncology research : POR · 2019
    Review
  11. Article
  12. Article
  13. Review
  14. Interaction of the epigenetic integrator UHRF1 with the MYST domain of TIP60 inside the cell.Journal of experimental & clinical cancer research : CR · 2017
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Awad ShammaDivision of Oncology and Molecular Biology, Kanazawa University, Kanazawa, Ishikawa, Japan.
Misa Suzuki
Naoyuki Hayashi
Masahiko Kobayashi
Nobunari Sasaki
Takumi Nishiuchi
Yuichiro Doki
Takahiro Okamoto
Susumu Kohno
Hayato Muranaka
Shunsuke Kitajima
Ken-Ichi Yamamoto
Chiaki Takahashi
Kanazawa University · JPOsaka University · JPTokyo Women's Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The retinoblastoma tumor suppressor gene (RB) product has been implicated in epigenetic control of gene expression owing to its ability to physically bind to many chromatin modifiers. However, the biological and clinical significance of this activity was not well elucidated. To address this, we performed genetic and epigenetic analyses in an Rb-deficient mouse thyroid C cell tumor model. Here we report that the genetic interaction of Rb and ATM regulates DNMT1 protein stability and hence controls the DNA methylation status in the promoters of at least the Ink4a, Shc2, FoxO6, and Noggin genes. Furthermore, we demonstrate that inactivation of pRB promotes Tip60 (acetyltransferase)-dependent ATM activation; allows activated ATM to physically bind to DNMT1, forming a complex with Tip60 and UHRF1 (E3 ligase); and consequently accelerates DNMT1 ubiquitination driven by Tip60-dependent acetylation. Our results indicate that inactivation of the pRB pathway in coordination with aberration in the DNA damage response deregulates DNMT1 stability, leading to an abnormal DNA methylation pattern and malignant progression.

Indexed as

DNA MethylationAnimalsAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCells, CulturedCyclin-Dependent Kinase Inhibitor p16DNA-Binding ProteinsDNA (Cytosine-5-)-Methyltransferase 1DNA (Cytosine-5-)-MethyltransferasesEmbryo, MammalianEnzyme StabilityGene DeletionGene Expression Regulation, NeoplasticHumansMiceMice, Inbred C57BLAtaxia Telangiectasia Mutated ProteinsATM protein, humanAtm protein, mouseCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p16DNA-Binding ProteinsDNA (Cytosine-5-)-Methyltransferase 1DNA (Cytosine-5-)-MethyltransferasesDNMT1 protein, humanDnmt1 protein, mouseProtein Serine-Threonine KinasesRetinoblastoma ProteinTumor Suppressor Proteins

Identifiers

PMID23754744
PMCPMC3753918
OpenAlexW797018034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.